ABEO logo

Abeona Therapeutics (ABEO) EBITDA

Annual EBITDA

-$50.57 M
-$16.19 M-47.08%

December 31, 2023

Summary

Performance

1-Year Change

-47.08%

3-Year Change

+32.13%

5-Year Change

+6.87%

15-Year Change

-90.33%

ABEO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.42%
ABEO annual EBITDA is higher than 32.42% of companies in Healthcare sector

High & Low

All-time High

$4.73 M
ABEO annual EBITDA is currently -1168.95% below its historical high of $4.73 million

3-Year Low

-$76.82 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABEO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 18, 2025
ABEO next annual earnings announcement is scheduled for Mar 18, 2025

OtherABEOprofitabilitymetrics:

Annual Revenue

$3.50 M
ABEO annual revenue is $3.50 million

Annual Net Income

-$54.19 M
ABEO annual net profit is -$54.19 million

Annual EBIT

-$53.77 M
ABEO annual earnings before interest & taxes is -$53.77 million

Annual EPS

-$2.53
ABEO annual earnings per share is -$2.53

Quarterly EBITDA

-$28.45 M
-$37.61 M-410.43%

September 30, 2024

Summary

Performance

3-Month Change

-410.43%

1-Year Change

-80.48%

3-Year Change

-439.04%

5-Year Change

-88.34%

ABEO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.44%
ABEO quarterly EBITDA is higher than 16.44% of companies in Healthcare sector

High & Low

All-time High

$20.24 M
ABEO quarterly EBITDA is currently -240.55% below its historical high of $20.24 million

3-Year Low

-$45.43 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
ABEO next earnings announcement is scheduled for Mar 18, 2025

OtherABEOprofitabilitymetrics:

Quarterly Revenue

-
ABEO quarterly revenue value is unknown

Quarterly Net Income

-$30.27 M
ABEO quarterly net profit is -$30.27 million

Quarterly EBIT

-$29.17 M
ABEO quarterly earnings before interest & taxes is -$29.17 million

Quarterly EPS

-$0.63
ABEO quarterly earnings per share is -$0.63

TTM EBITDA

-$64.94 M
-$17.46 M-36.78%

September 30, 2024

Summary

Performance

3-Month Change

-36.78%

1-Year Change

-28.42%

3-Year Change

-45.23%

5-Year Change

+3.36%

ABEO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.44%
ABEO TTM EBITDA is higher than 26.44% of companies in Healthcare sector

High & Low

All-time High

$25.95 M
ABEO TTM EBITDA is currently -350.29% below its historical high of $25.95 million

3-Year Low

-$84.05 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
ABEO next earnings announcement is scheduled for Mar 18, 2025

OtherABEOprofitabilitymetrics:

TTM Revenue

-
ABEO TTM revenue value is unknown

TTM Net Income

-$71.03 M
ABEO TTM net profit is -$71.03 million

TTM EBIT

-$67.80 M
ABEO TTM earnings before interest & taxes is -$67.80 million

TTM EPS

-$2.69
ABEO TTM earnings per share is -$2.69

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$50.57 M
ABEO annual EBITDA is -$50.57 million

Annual Net Income

-$54.19 M
ABEO annual net profit is -$54.19 million

Annual Interest Expense

$418.00 K
ABEO annual interest expense is $418.00 thousand

Annual Income Tax

-
ABEO annual income tax value is unknown

Annual D&A

$3.20 M
ABEO annual depreciation & amortization is $3.20 million

ABEO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-47.1%-80.5%-28.4%
3 y3 years+32.1%-439.0%-45.2%
5 y5 years+6.9%-88.3%+3.4%

ABEO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-47.1%+34.2%-410.4%+37.4%-198.3%+22.7%
5 y5-year-47.1%+34.2%-410.4%+37.4%-198.3%+32.1%
alltimeall time-1169.0%+34.2%-240.6%+37.4%-350.3%+32.1%

Abeona Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$28.45 M(-410.4%)
-$64.94 M(+36.8%)
Jun 2024
-
$9.16 M(-130.6%)
-$47.48 M(-34.4%)
Mar 2024
-
-$29.90 M(+89.7%)
-$72.36 M(+43.1%)
Dec 2023
-$50.57 M(+47.1%)
-$15.76 M(+43.5%)
-$50.57 M(+24.1%)
Sep 2023
-
-$10.98 M(-30.1%)
-$40.74 M(+16.6%)
Jun 2023
-
-$15.71 M(+93.6%)
-$34.96 M(+60.6%)
Mar 2023
-
-$8.12 M(+36.8%)
-$21.77 M(-36.7%)
Dec 2022
-$34.38 M(-55.2%)
-$5.93 M(+14.3%)
-$34.38 M(-53.5%)
Sep 2022
-
-$5.19 M(+105.5%)
-$73.88 M(-0.1%)
Jun 2022
-
-$2.53 M(-87.8%)
-$73.97 M(-12.0%)
Mar 2022
-
-$20.73 M(-54.4%)
-$84.05 M(+9.4%)
Dec 2021
-$76.82 M(+3.1%)
-$45.43 M(+761.0%)
-$76.82 M(+71.8%)
Sep 2021
-
-$5.28 M(-58.1%)
-$44.72 M(+1.1%)
Jun 2021
-
-$12.61 M(-6.6%)
-$44.25 M(+3.5%)
Mar 2021
-
-$13.50 M(+1.2%)
-$42.77 M(-42.6%)
Dec 2020
-$74.52 M(+10.9%)
-$13.34 M(+177.4%)
-$74.52 M(-0.5%)
Sep 2020
-
-$4.81 M(-56.8%)
-$74.90 M(-12.1%)
Jun 2020
-
-$11.13 M(-75.4%)
-$85.20 M(-11.0%)
Mar 2020
-
-$45.25 M(+229.8%)
-$95.71 M(+42.4%)
Dec 2019
-$67.20 M(+23.8%)
-$13.72 M(-9.2%)
-$67.20 M(-3.4%)
Sep 2019
-
-$15.10 M(-30.2%)
-$69.57 M(-1.1%)
Jun 2019
-
-$21.64 M(+29.2%)
-$70.38 M(+16.0%)
Mar 2019
-
-$16.75 M(+4.1%)
-$60.69 M(+11.8%)
Dec 2018
-$54.30 M(+104.4%)
-$16.09 M(+1.1%)
-$54.30 M(+16.7%)
Sep 2018
-
-$15.91 M(+33.1%)
-$46.52 M(+29.9%)
Jun 2018
-
-$11.95 M(+15.4%)
-$35.81 M(+12.2%)
Mar 2018
-
-$10.35 M(+24.7%)
-$31.93 M(+20.2%)
Dec 2017
-$26.57 M(+26.3%)
-$8.30 M(+59.6%)
-$26.57 M(+6.2%)
Sep 2017
-
-$5.20 M(-35.5%)
-$25.02 M(+12.6%)
Jun 2017
-
-$8.07 M(+61.5%)
-$22.22 M(+7.5%)
Mar 2017
-
-$5.00 M(-26.0%)
-$20.67 M(-1.8%)
Dec 2016
-$21.04 M(+50.6%)
-$6.75 M(+181.2%)
-$21.04 M(+27.7%)
Sep 2016
-
-$2.40 M(-63.2%)
-$16.48 M(-17.6%)
Jun 2016
-
-$6.52 M(+21.5%)
-$20.00 M(+14.6%)
Mar 2016
-
-$5.37 M(+145.3%)
-$17.46 M(+25.0%)
Dec 2015
-$13.97 M(-46.7%)
-$2.19 M(-63.0%)
-$13.97 M(-40.7%)
Sep 2015
-
-$5.92 M(+48.8%)
-$23.54 M(+24.3%)
Jun 2015
-
-$3.98 M(+111.5%)
-$18.94 M(-30.7%)
Mar 2015
-
-$1.88 M(-84.0%)
-$27.33 M(+4.4%)
Dec 2014
-$26.18 M(-653.5%)
-$11.76 M(+790.1%)
-$26.18 M(+70.0%)
Sep 2014
-
-$1.32 M(-89.3%)
-$15.40 M(+8.9%)
Jun 2014
-
-$12.37 M(+1578.3%)
-$14.14 M(>+9900.0%)
Mar 2014
-
-$737.00 K(-24.6%)
-$130.00 K(-102.7%)
Dec 2013
$4.73 M(-149.8%)
-$977.00 K(+1528.3%)
$4.73 M(-81.8%)
Sep 2013
-
-$60.00 K(-103.6%)
$25.95 M(+128.7%)
Jun 2013
-
$1.64 M(-60.1%)
$11.35 M(-1695.6%)
Mar 2013
-
$4.13 M(-79.6%)
-$711.00 K(-92.5%)
Dec 2012
-$9.51 M(+316.5%)
$20.24 M(-238.0%)
-$9.51 M(-63.5%)
Sep 2012
-
-$14.66 M(+40.8%)
-$26.02 M(+98.9%)
Jun 2012
-
-$10.41 M(+123.0%)
-$13.08 M(+169.0%)
Mar 2012
-
-$4.67 M(-225.2%)
-$4.86 M(+113.1%)
Dec 2011
-$2.28 M
$3.73 M(-315.7%)
-$2.28 M(-67.4%)
Sep 2011
-
-$1.73 M(-21.2%)
-$7.00 M(-6.8%)
DateAnnualQuarterlyTTM
Jun 2011
-
-$2.19 M(+5.1%)
-$7.51 M(+4.3%)
Mar 2011
-
-$2.09 M(+110.5%)
-$7.20 M(+7.6%)
Dec 2010
-$6.69 M(-28.9%)
-$992.00 K(-55.7%)
-$6.69 M(-8.6%)
Sep 2010
-
-$2.24 M(+18.9%)
-$7.32 M(-18.3%)
Jun 2010
-
-$1.88 M(+18.9%)
-$8.96 M(-1.6%)
Mar 2010
-
-$1.58 M(-2.5%)
-$9.11 M(-3.3%)
Dec 2009
-$9.42 M(-69.0%)
-$1.62 M(-58.1%)
-$9.42 M(-0.4%)
Sep 2009
-
-$3.88 M(+91.3%)
-$9.45 M(+1.3%)
Jun 2009
-
-$2.03 M(+7.0%)
-$9.33 M(-0.7%)
Mar 2009
-
-$1.89 M(+14.2%)
-$9.40 M(-47.8%)
Dec 2008
-$30.41 M(+67.8%)
-$1.66 M(-55.9%)
-$18.00 M(-39.4%)
Sep 2008
-
-$3.76 M(+79.8%)
-$29.69 M(+7.9%)
Jun 2008
-
-$2.09 M(-80.1%)
-$27.52 M(+2.1%)
Mar 2008
-
-$10.50 M(-21.4%)
-$26.97 M(+70.6%)
Dec 2007
-$18.12 M(-1062.5%)
-$13.35 M(+739.4%)
-$15.81 M(+1712.8%)
Sep 2007
-
-$1.59 M(+3.6%)
-$872.00 K(-176.4%)
Jun 2007
-
-$1.53 M(-331.5%)
$1.14 M(-61.7%)
Mar 2007
-
$663.00 K(-58.3%)
$2.98 M(+58.4%)
Dec 2006
$1.88 M(-123.4%)
$1.59 M(+275.0%)
$1.88 M(-151.7%)
Sep 2006
-
$424.00 K(+39.0%)
-$3.65 M(-25.9%)
Jun 2006
-
$305.00 K(-170.0%)
-$4.92 M(-33.7%)
Mar 2006
-
-$436.00 K(-88.9%)
-$7.41 M(-7.9%)
Dec 2005
-$8.05 M(+63.3%)
-$3.94 M(+363.8%)
-$8.05 M(+144.9%)
Sep 2005
-
-$849.00 K(-61.2%)
-$3.29 M(-25.7%)
Jun 2005
-
-$2.19 M(+104.5%)
-$4.42 M(+6.0%)
Mar 2005
-
-$1.07 M(-230.0%)
-$4.17 M(-15.4%)
Dec 2004
-$4.93 M(+8.8%)
$824.00 K(-141.6%)
-$4.93 M(-3.4%)
Sep 2004
-
-$1.98 M(+2.3%)
-$5.10 M(+5.5%)
Jun 2004
-
-$1.94 M(+6.0%)
-$4.84 M(+10.6%)
Mar 2004
-
-$1.83 M(-382.3%)
-$4.37 M(-3.4%)
Dec 2003
-$4.53 M(-43.5%)
$648.00 K(-137.8%)
-$4.53 M(-36.3%)
Sep 2003
-
-$1.72 M(+16.2%)
-$7.11 M(-9.7%)
Jun 2003
-
-$1.48 M(-25.5%)
-$7.87 M(-5.7%)
Mar 2003
-
-$1.98 M(+2.6%)
-$8.35 M(+4.1%)
Dec 2002
-$8.01 M(+41.1%)
-$1.93 M(-22.0%)
-$8.01 M(+7.6%)
Sep 2002
-
-$2.48 M(+26.9%)
-$7.45 M(+11.8%)
Jun 2002
-
-$1.95 M(+18.2%)
-$6.66 M(+8.3%)
Mar 2002
-
-$1.65 M(+21.0%)
-$6.15 M(+8.2%)
Dec 2001
-$5.68 M(+1.8%)
-$1.36 M(-19.5%)
-$5.68 M(-4.9%)
Sep 2001
-
-$1.70 M(+17.8%)
-$5.97 M(+5.5%)
Jun 2001
-
-$1.44 M(+21.6%)
-$5.66 M(-2.0%)
Mar 2001
-
-$1.18 M(-28.5%)
-$5.78 M(+3.5%)
Dec 2000
-$5.58 M(+83.1%)
-$1.65 M(+19.6%)
-$5.58 M(+16.8%)
Sep 2000
-
-$1.38 M(-11.1%)
-$4.78 M(+22.7%)
Jun 2000
-
-$1.55 M(+57.2%)
-$3.89 M(+24.1%)
Mar 2000
-
-$989.00 K(+16.4%)
-$3.14 M(+6.4%)
Dec 1999
-$3.05 M(-7.6%)
-$850.00 K(+70.3%)
-$2.95 M(+40.5%)
Sep 1999
-
-$499.00 K(-37.6%)
-$2.10 M(+31.2%)
Jun 1999
-
-$800.00 K(+0.1%)
-$1.60 M(+100.1%)
Mar 1999
-
-$799.00 K
-$799.00 K
Dec 1998
-$3.30 M(-24.3%)
-
-
Dec 1997
-$4.36 M(-62.0%)
-
-
Dec 1996
-$11.49 M(-3327.5%)
-
-
Dec 1995
$356.00 K
-
-

FAQ

  • What is Abeona Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Abeona Therapeutics?
  • What is Abeona Therapeutics annual EBITDA year-on-year change?
  • What is Abeona Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Abeona Therapeutics?
  • What is Abeona Therapeutics quarterly EBITDA year-on-year change?
  • What is Abeona Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Abeona Therapeutics?
  • What is Abeona Therapeutics TTM EBITDA year-on-year change?

What is Abeona Therapeutics annual EBITDA?

The current annual EBITDA of ABEO is -$50.57 M

What is the all time high annual EBITDA for Abeona Therapeutics?

Abeona Therapeutics all-time high annual EBITDA is $4.73 M

What is Abeona Therapeutics annual EBITDA year-on-year change?

Over the past year, ABEO annual EBITDA has changed by -$16.19 M (-47.08%)

What is Abeona Therapeutics quarterly EBITDA?

The current quarterly EBITDA of ABEO is -$28.45 M

What is the all time high quarterly EBITDA for Abeona Therapeutics?

Abeona Therapeutics all-time high quarterly EBITDA is $20.24 M

What is Abeona Therapeutics quarterly EBITDA year-on-year change?

Over the past year, ABEO quarterly EBITDA has changed by -$12.68 M (-80.48%)

What is Abeona Therapeutics TTM EBITDA?

The current TTM EBITDA of ABEO is -$64.94 M

What is the all time high TTM EBITDA for Abeona Therapeutics?

Abeona Therapeutics all-time high TTM EBITDA is $25.95 M

What is Abeona Therapeutics TTM EBITDA year-on-year change?

Over the past year, ABEO TTM EBITDA has changed by -$14.37 M (-28.42%)